Diagnostic MALDI-TOF MS can differentiate between high and low toxic Staphylococcus aureus bacteraemia isolates as a predictor of patient outcome

References

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520–532 [View Article] [PubMed]
   [Google Scholar]
2. Kwiecinski JM, Horswill AR. Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms. Curr Opin Microbiol 2020; 53:51–60 [View Article] [PubMed]
   [Google Scholar]
3. Bai AD, Lo CKL, Komorowski AS, Suresh M, Guo K et al. Staphylococcus aureus bacteremia mortality: a systematic review and meta-analysis. Clin Microbiol InfectS1198-743X(22)00154-9 2022; 23 [View Article]
   [Google Scholar]
4. Jenkins A, Diep BA, Mai TT, Vo NH, Warrener P et al. Differential expression and roles of Staphylococcus aureus virulence determinants during colonization and disease. mBio 2015; 6:e02272–14 [View Article] [PubMed]
   [Google Scholar]
5. Recker M, Laabei M, Toleman MS, Reuter S, Saunderson RB et al. Clonal differences in Staphylococcus aureus bacteraemia-associated mortality. Nat Microbiol 2017; 2:1381–1388 [View Article] [PubMed]
   [Google Scholar]
6. Rudkin JK, McLoughlin RM, Preston A, Massey RC et al. Bacterial toxins: offensive, defensive, or something else altogether?. PLoS Pathog 2017; 13:e1006452 [View Article] [PubMed]
   [Google Scholar]
7. Novick RP, Geisinger E. Quorum sensing in staphylococci. Annu Rev Genet 2008; 42:541–564 [View Article] [PubMed]
   [Google Scholar]
8. Laabei M, Uhlemann A-C, Lowy FD, Austin ED, Yokoyama M et al. Evolutionary trade-offs underlie the multi-faceted virulence of Staphylococcus aureus. PLoS Biol 2015; 13:e1002229 [View Article] [PubMed]
   [Google Scholar]
9. Rose HR, Holzman RS, Altman DR, Smyth DS, Wasserman GA et al. Cytotoxic virulence predicts mortality in nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus. J Infect Dis 2015; 211:1862–1874 [View Article] [PubMed]
   [Google Scholar]
10. Lee C-C, Lee C-H, Hong M-Y, Tang H-J, Ko W-C et al. Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia. Crit Care 2017; 21:119 [View Article] [PubMed]
    [Google Scholar]
11. Otto MP, Martin E, Badiou C, Lebrun S, Bes M et al. Effects of subinhibitory concentrations of antibiotics on virulence factor expression by community-acquired methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2013; 68:1524–1532 [View Article] [PubMed]
    [Google Scholar]
12. Hodille E, Badiou C, Bouveyron C, Bes M, Tristan A et al. Clindamycin suppresses virulence expression in inducible clindamycin-resistant Staphylococcus aureus strains. Ann Clin Microbiol Antimicrob 2018; 17:38 [View Article] [PubMed]
    [Google Scholar]
13. Gottlieb M, Long B, Koyfman A. The evaluation and management of toxic shock syndrome in the emergency department: a review of the literature. J Emerg Med 2018; 54:807–814 [View Article] [PubMed]
    [Google Scholar]
14. Bonne SL, Kadri SS. Evaluation and management of necrotizing soft tissue infections. Infect Dis Clin North Am 2017; 31:497–511 [View Article] [PubMed]
    [Google Scholar]
15. Campbell AJ, Dotel R, Blyth CC, Davis JS, Tong SYC et al. Adjunctive protein synthesis inhibitor antibiotics for toxin suppression in Staphylococcus aureus infections: a systematic appraisal. J Antimicrob Chemother 2019; 74:1–5 [View Article] [PubMed]
    [Google Scholar]
16. Health Protection Agency Guidance on the diagnosis and management of PVL-associated Staphylococcus aureus infections (PVL-SA) in England. Report prepared by the PVL sub-group of the Steering Group on Healthcare Associated Infection; 2008 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/322857/Guidance_on_the_diagnosis_and_management_of_PVL_associated_SA_infections_in_England_2_Ed.pdf
17. Lamy B, Sundqvist M, Idelevich EA. Bloodstream infections - standard and progress in pathogen diagnostics. Clin Microbiol Infect 2020; 26:142–150 [View Article] [PubMed]
    [Google Scholar]
18. Welker M, Moore ERB. Applications of whole-cell matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry in systematic microbiology. Syst Appl Microbiol 2011; 34:2–11 [View Article] [PubMed]
    [Google Scholar]
19. R Core Team R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2020 https://www.R-project.org/
20. Gagnaire J, Dauwalder O, Boisset S, Khau D, Freydière A-M et al. Detection of Staphylococcus aureus delta-toxin production by whole-cell MALDI-TOF mass spectrometry. PLoS One 2012; 7:e40660 [View Article] [PubMed]
    [Google Scholar]
21. Janzon L, Arvidson S. The role of the delta-lysin gene (hld) in the regulation of virulence genes by the accessory gene regulator (agr) in Staphylococcus aureus. EMBO J 1990; 9:1391–1399 [View Article] [PubMed]
    [Google Scholar]
22. Wang R, Braughton KR, Kretschmer D, Bach T-HL, Queck SY et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 2007; 13:1510–1514 [View Article] [PubMed]
    [Google Scholar]
23. Tong SYC, Mora J, Bowen AC, Cheng MP, Daneman N et al. The Staphylococcus aureus network adaptive platform trial protocol: new tools for an old foe. Clin Infect Dis 2022ciac476 [View Article]
    [Google Scholar]
24. Laabei M, Peacock SJ, Blane B, Baines SL, Howden BP et al. Significant variability exists in the cytotoxicity of global methicillin-resistant Staphylococcus aureus lineages. Microbiology 2021; 167:12 [View Article] [PubMed]
    [Google Scholar]
25. Fey PD, Endres JL, Yajjala VK, Widhelm TJ, Boissy RJ et al. A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes. mBio 2013; 4:e00537-12 [View Article]
    [Google Scholar]